Filing Details
Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) filed a Form 8-K with the Securities and Exchange Commission on October 16, 2026, disclosing a material event.
8k filedNASDAQ:OACC
Oaktree Acquisition Corp. III Life Sciences (OACC) Reports Material Event to SEC
Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) filed a Form 8-K with the Securities and Exchange Commission on October 16, 2026, disclosing a material event.
At publication ·
What changed
Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Oaktree Acquisition Corp. III Life Sciences filed a Form 8-K on October 16, 2026, disclosing a material event to shareholders.
- The company's stock traded at $10.70 with a market capitalization of $259.9 million at the time of the filing.
- Material events reported on Form 8-K can include leadership changes, acquisitions, asset sales, or changes to financial guidance.
Market Context
Oaktree Acquisition Corp. III Life Sciences's stock currently trades at $10.70 with a market capitalization of $259.9M. The Financial Services company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Oaktree Acquisition Corp. III Life Sciences's stock.
All SEC filings for Oaktree Acquisition Corp. III Life Sciences are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View OACC Stock Page
Frequently Asked Questions
Where can I read OACC's SEC filings?
Browse all filings on our OACC SEC filings page.
What types of SEC filings does Oaktree Acquisition Corp. III Life Sciences file?
Public companies like Oaktree Acquisition Corp. III Life Sciences file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.